{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:02:04Z","timestamp":1792807324926,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antimicrobial resistance (AMR) is affected by many factors, but too much of our focus has been on antimicrobial usage. The major factor that drives resistance rates globally is spread. The COVID-19 pandemic should lead to improved infection prevention and control practices, both in healthcare facilities and the community. COVID-19 will also have ongoing and profound effects on local, national and international travel. All these factors should lead to a decrease in the spread of resistant bacteria. So overall, COVID-19 should lead to a fall in resistance rates seen in many countries. For this debate we show why, overall, COVID-19 will not result in increased AMR prevalence. But globally, changes in AMR rates will not be uniform. In wealthier and developed countries, resistance rates will likely decrease, but in many other countries there are already too many factors associated with poor controls on the spread of bacteria and viruses (e.g. poor water and sanitation, poor public health, corrupt government, inadequate housing, etc.). In these countries, if economies and governance deteriorate further, we might see even more transmission of resistant bacteria.<\/jats:p>","DOI":"10.1093\/jacamr\/dlaa051","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T19:07:25Z","timestamp":1594753645000},"source":"Crossref","is-referenced-by-count":54,"title":["CON: COVID-19 will not result in increased antimicrobial resistance prevalence"],"prefix":"10.1093","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-9203","authenticated-orcid":false,"given":"Peter","family":"Collignon","sequence":"first","affiliation":[{"name":"Australian Capital Territory Pathology, Canberra Hospital, Garran, Australian Capital Territory, Australia"},{"name":"Medical School, Australian National University, Canberra, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Beggs","sequence":"additional","affiliation":[{"name":"Monarch Institute, 10 Queen St, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"2022012811554013100_dlaa051-B1","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/S2542-5196(18)30186-4","article-title":"Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis","volume":"2","author":"Collignon","year":"2018","journal-title":"Lancet Planet Health"},{"key":"2022012811554013100_dlaa051-B2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1473-3099(18)30714-X","article-title":"An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial","volume":"19","author":"Mitchell","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022012811554013100_dlaa051-B3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/CMR.00020-14","article-title":"Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination","volume":"27","author":"Dancer","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2022012811554013100_dlaa051-B4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022012811554013100_dlaa051-B5"},{"key":"2022012811554013100_dlaa051-B6","doi-asserted-by":"crossref","first-page":"E10596","DOI":"10.1073\/pnas.1702472114","article-title":"Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8","volume":"114","author":"Strau\u00df","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022012811554013100_dlaa051-B7","doi-asserted-by":"crossref","first-page":"e01105-19","DOI":"10.1128\/mBio.01105-19","article-title":"Evolution and global transmission of a multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus lineage from the Indian subcontinent","volume":"10","author":"Steinig","year":"2019","journal-title":"mBio"},{"key":"2022012811554013100_dlaa051-B8","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","article-title":"Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network","volume":"39","author":"McGee","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2022012811554013100_dlaa051-B9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2022012811554013100_dlaa051-B10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"2022012811554013100_dlaa051-B11","first-page":"842","article-title":"Antibiotic resistance pattern among common bacterial uropathogens with special reference to ciprofloxacin resistant Escherichia coli","volume":"136","author":"Mandal","year":"2012","journal-title":"Indian J Med Res"},{"key":"2022012811554013100_dlaa051-B12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5694\/j.1326-5377.2008.tb01586.x","article-title":"Escherichia coli bacteraemia in Canberra: incidence and clinical features","volume":"188","author":"Kennedy","year":"2008","journal-title":"Med J Aust"},{"key":"2022012811554013100_dlaa051-B13","author":"Joseph","year":"2019"},{"key":"2022012811554013100_dlaa051-B14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/tropicalmed4010022","article-title":"One Health\u2014its importance in helping to better control antimicrobial resistance","volume":"4","author":"Collignon","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"2022012811554013100_dlaa051-B15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/cid\/cit355","article-title":"The scourge of antibiotic resistance: the important role of the environment","volume":"57","author":"Finley","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022012811554013100_dlaa051-B16","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/jtm\/taw101","article-title":"Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level","volume":"24","author":"Woerther","year":"2017","journal-title":"J Travel Med"},{"key":"2022012811554013100_dlaa051-B17","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.tmaid.2019.101547","article-title":"Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: a cross-sectional study","volume":"33","author":"Arcilla","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2022012811554013100_dlaa051-B18","doi-asserted-by":"crossref","first-page":"taz083","DOI":"10.1093\/jtm\/taz083","article-title":"Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: a synthesis of cumulative evidence","volume":"27","author":"Furuya-Kanamori","year":"2020","journal-title":"J Travel Med"},{"key":"2022012811554013100_dlaa051-B19","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10096-010-1031-y","article-title":"Colonisation with Escherichia coli resistant to \u201ccritically important\u201d antibiotics: a high risk for international travellers","volume":"29","author":"Kennedy","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"2022012811554013100_dlaa051-B20","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"2022012811554013100_dlaa051-B21","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012811554013100_dlaa051-B22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2022012811554013100_dlaa051-B23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"2022012811554013100_dlaa051-B24","doi-asserted-by":"crossref","first-page":"e0116746","DOI":"10.1371\/journal.pone.0116746","article-title":"Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem","volume":"10","author":"Collignon","year":"2015","journal-title":"PLoS One"},{"key":"2022012811554013100_dlaa051-B25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/2\/3\/dlaa051\/42320895\/jacamr_2_3_dlaa051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/2\/3\/dlaa051\/42320895\/jacamr_2_3_dlaa051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:58:38Z","timestamp":1643371118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlaa051\/5872562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlaa051","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,7,17]]},"article-number":"dlaa051"}}